• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂质谱综合分析预测恶性胆道肿瘤患者的临床结局。

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor.

机构信息

Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC & Chinese Academy of Medical Sciences, Beijing, 100730, China.

Peking Union Medical College (PUMC), PUMC & Chinese Academy of Medical Sciences, Beijing, 100730, China.

出版信息

BMC Cancer. 2020 Oct 9;20(1):980. doi: 10.1186/s12885-020-07496-8.

DOI:10.1186/s12885-020-07496-8
PMID:33036576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7547451/
Abstract

BACKGROUND

Serum lipids were reported to be the prognostic factors of various cancers, but their prognostic value in malignant biliary tumor (MBT) patients remains unclear. Thus we aim to assess and compare prognosis values of different serum lipids, and construct a novel prognostic nomogram based on serum lipids.

METHODS

Patients with a confirmed diagnosis of MBT at our institute from 2003 to 2017 were retrospectively reviewed. Prognosis-related factors were identified via univariate and multivariate Cox regression analyses. Then the novel prognostic nomogram and a 3-tier staging system were constructed based on these factors and further compared to the TNM staging system.

RESULTS

A total of 368 patients were included in this study. Seven optimal survival-related factors-TC/HDL >  10.08, apolipoprotein B >  0.9 g/L, lipoprotein> 72 mg/L, lymph node metastasis, radical cure, CA199 > 37 U/mL, and tumor differentiation -were included to construct the prognostic nomogram. The C-indexes in training and validation sets were 0.738 and 0.721, respectively. Besides, ROC curves, calibration plots, and decision curve analysis all suggested favorable discrimination and predictive ability. The nomogram also performed better predictive ability than the TNM system and nomogram without lipid parameters. And the staging system based on nomogram also presented better discriminative ability than TNM system (P < 0.001).

CONCLUSIONS

The promising prognostic nomogram based on lipid parameters provided an intuitive method for performing survival prediction and facilitating individualized treatment and was a great complement to the TNM staging system in predicting overall survival.

摘要

背景

血清脂质被报道为各种癌症的预后因素,但它们在恶性胆道肿瘤(MBT)患者中的预后价值尚不清楚。因此,我们旨在评估和比较不同血清脂质的预后价值,并构建基于血清脂质的新的预后列线图。

方法

回顾性分析了 2003 年至 2017 年在我院确诊为 MBT 的患者。通过单因素和多因素 Cox 回归分析确定与预后相关的因素。然后,根据这些因素构建新的预后列线图和 3 级分期系统,并与 TNM 分期系统进行比较。

结果

本研究共纳入 368 例患者。包括 7 个与生存相关的最佳因素:TC/HDL>10.08、载脂蛋白 B>0.9g/L、脂蛋白>72mg/L、淋巴结转移、根治性治疗、CA199>37U/ml 和肿瘤分化。纳入构建预后列线图。训练集和验证集的 C 指数分别为 0.738 和 0.721。此外,ROC 曲线、校准图和决策曲线分析均表明该列线图具有良好的判别和预测能力。该列线图也比 TNM 系统和无脂质参数的列线图具有更好的预测能力。基于列线图的分期系统也比 TNM 系统具有更好的判别能力(P<0.001)。

结论

基于脂质参数的有前途的预后列线图为生存预测提供了一种直观的方法,有助于个体化治疗,是对 TNM 分期系统预测总生存期的很好补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/c7d8ca395e23/12885_2020_7496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/30e0fa321df9/12885_2020_7496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/705b1db20e35/12885_2020_7496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/0cda700c3711/12885_2020_7496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/c7d8ca395e23/12885_2020_7496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/30e0fa321df9/12885_2020_7496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/705b1db20e35/12885_2020_7496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/0cda700c3711/12885_2020_7496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aca/7547451/c7d8ca395e23/12885_2020_7496_Fig4_HTML.jpg

相似文献

1
Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor.血清脂质谱综合分析预测恶性胆道肿瘤患者的临床结局。
BMC Cancer. 2020 Oct 9;20(1):980. doi: 10.1186/s12885-020-07496-8.
2
Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.纳入血液学标志物和临床特征的鼻咽癌患者预后列线图。
Int J Biol Sci. 2018 Apr 5;14(5):549-556. doi: 10.7150/ijbs.24374. eCollection 2018.
3
Prognostic nomogram integrated baseline serum lipids for patients with non-esophageal squamous cell carcinoma.非食管鳞状细胞癌患者的预后列线图综合了基线血脂指标。
Ann Transl Med. 2019 Oct;7(20):548. doi: 10.21037/atm.2019.09.86.
4
Analysis of Baseline Serum Lipid Profile for Predicting Clinical Outcomes of Patients with Extensive-Stage Small Cell Lung Cancer.分析基线血脂谱以预测广泛期小细胞肺癌患者的临床结局
Cancer Manag Res. 2023 Jul 27;15:773-783. doi: 10.2147/CMAR.S418487. eCollection 2023.
5
Comparison of Prognostic Value of Red Cell-Related Parameters of Biliary Tract Cancer After Surgical Resection and Integration of a Prognostic Nomogram: A Retrospective Study.比较胆道癌手术后红细胞相关参数的预后价值和预后列线图的整合:一项回顾性研究。
Adv Ther. 2021 Feb;38(2):1227-1244. doi: 10.1007/s12325-020-01595-5. Epub 2020 Dec 26.
6
Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.建立一个列线图,通过整合分子标志物和肿瘤-淋巴结-转移分期系统来预测肝细胞癌的预后。
Dig Surg. 2019;36(5):426-432. doi: 10.1159/000494219. Epub 2018 Nov 27.
7
Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer.胆道癌患者生存预测的凝血指标综合分析。
BMC Cancer. 2021 Aug 25;21(1):953. doi: 10.1186/s12885-021-08684-w.
8
A New Nomogram for Predicting the Postoperative Overall Survival in Patients with Middle-Aged and Elderly Rectal Cancer: A Single Center Retrospective Study in Chinese Population.一种预测中老年直肠癌患者术后总生存期的新列线图:中国人群单中心回顾性研究
Int J Gen Med. 2022 May 25;15:5197-5209. doi: 10.2147/IJGM.S365947. eCollection 2022.
9
Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer.基于乳腺癌阳性淋巴结对数比值(LODDS)的预后列线图的开发与验证
Oncotarget. 2016 Apr 12;7(15):21046-53. doi: 10.18632/oncotarget.8091.
10
Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.肉瘤样肝细胞癌列线图预后评估模型的建立与验证。
Adv Ther. 2020 Jul;37(7):3185-3205. doi: 10.1007/s12325-020-01357-3. Epub 2020 May 20.

引用本文的文献

1
Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patients.血脂代谢生物标志物正逐渐成为癌症患者生存的重要预后指标。
BMC Cancer. 2024 Dec 18;24(1):1549. doi: 10.1186/s12885-024-13265-8.
2
Apolipoproteins: New players in cancers.载脂蛋白:癌症中的新角色。
Front Pharmacol. 2022 Nov 25;13:1051280. doi: 10.3389/fphar.2022.1051280. eCollection 2022.

本文引用的文献

1
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.癌症中的胆固醇代谢:机制与治疗机遇。
Nat Metab. 2020 Feb;2(2):132-141. doi: 10.1038/s42255-020-0174-0. Epub 2020 Feb 10.
2
Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling.脂肪甘油三酯脂肪酶活性通过 AMP 激酶和 mTOR 信号通路调节癌细胞增殖。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158737. doi: 10.1016/j.bbalip.2020.158737. Epub 2020 May 11.
3
A Novel Clinically Based Staging System for Gallbladder Cancer.
一种新的基于临床的胆囊癌分期系统。
J Natl Compr Canc Netw. 2020 Feb;18(2):151-159. doi: 10.6004/jnccn.2019.7357.
4
Prognostic nomogram integrated baseline serum lipids for patients with non-esophageal squamous cell carcinoma.非食管鳞状细胞癌患者的预后列线图综合了基线血脂指标。
Ann Transl Med. 2019 Oct;7(20):548. doi: 10.21037/atm.2019.09.86.
5
Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer.胆囊癌切除术中淋巴结清扫生存获益列线图的构建与验证
Hepatobiliary Surg Nutr. 2019 Oct;8(5):480-489. doi: 10.21037/hbsn.2019.03.02.
6
Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma.载脂蛋白B升高预示肝细胞癌患者术后预后不良。
Onco Targets Ther. 2019 Mar 12;12:1957-1964. doi: 10.2147/OTT.S192631. eCollection 2019.
7
Intrahepatic cholangiocarcinoma, are we making progress?肝内胆管癌,我们有进展吗?
Hepatobiliary Surg Nutr. 2018 Apr;7(2):127-129. doi: 10.21037/hbsn.2017.12.14.
8
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.miRNA 特征作为低级别胶质瘤患者新型生物标志物的预后价值。
J Neurooncol. 2018 Mar;137(1):127-137. doi: 10.1007/s11060-017-2704-5. Epub 2017 Dec 4.
9
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature.临床预测模型的判别与校准:医学文献的使用者指南。
JAMA. 2017 Oct 10;318(14):1377-1384. doi: 10.1001/jama.2017.12126.
10
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers.《美国癌症联合委员会(AJCC)癌症分期手册》第8版:胰腺癌和肝胆癌
Ann Surg Oncol. 2018 Apr;25(4):845-847. doi: 10.1245/s10434-017-6025-x. Epub 2017 Jul 27.